SOPH
SOPHiA GENETICS SA
8.30$
+1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -74.6% | -66.2% | -92.8% | -65.9% | -45.2% | -59.8% | -60.5% | -44.8% | -45.2% | -41.2% | -74.6% | -33.0% | -48.3% | |
| 13.5% | 11.6% | 13.0% | 12.9% | 14.0% | 12.9% | 12.9% | 12.9% | 12.5% | 11.2% | 12.7% | 12.5% | 12.2% | |
| 24.1% | 24.7% | 23.5% | 25.8% | 22.8% | 28.6% | 21.6% | 23.8% | 21.3% | 17.8% | 15.3% | 19.3% | 18.4% | |
| 29.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -33.0% | 27.4% | -10.7% | -6.9% | 8.8% | -6.8% | -4.4% | 19.6% | 9.9% | 24.1% | -16.1% | 20.6% | 9.8% | |
| 12.9% | 13.2% | 12.4% | 12.4% | 14.6% | 10.9% | 8.4% | 10.8% | 0.5% | 1.6% | 4.0% | 11.6% | 4.7% | |
| -12.9% | -13.2% | -6.4% | -7.1% | -26.0% | -10.9% | -5.8% | -8.5% | -13.2% | -18.1% | -13.2% | -10.6% | -13.7% | |
| – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -4.6% | – | – | – | -4.2% | -3.4% | -2.6% | 186.3% | -2.6% | -2.2% | -2.6% | -2.7% | -2.5% | |
| -4.6% | -3.0% | -4.7% | 81.7% | -0.1% | -3.2% | -5.6% | 183.0% | -10.2% | 1.8% | 66.4% | 231.6% | 77.5% | |
| -96.8% | -55.8% | -123.7% | 10.5% | -60.6% | -87.8% | -65.8% | 143.5% | -67.9% | -52.2% | -22.6% | 181.4% | 14.9% | |
| -87.5% | -79.4% | -105.2% | -78.3% | -59.8% | -70.7% | -68.9% | -55.6% | -45.7% | -42.8% | -78.6% | -44.6% | -53.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.